South West Sydney Local Health District   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Liverpool Australia (2005)

Organization Overview

First Clinical Trial
2010
NCT01075802
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

South West Sydney Local Health District

Active Ingredients

Drugs in Phase 3 Trials (3)

baclofen (lioresal) (1 trial)

naltrexone (revia) (1 trial)

topiramate (topamax) (1 trial)

Drugs in Phase 2 Trials (2)

alteplase (Activase) (1 trial)

tiopronin (thiola) (1 trial)

Drugs in Phase 1 Trials (1)

cannabidiol (Epidiolex) (1 trial)

Drugs in Other Trials (1)

tamoxifen (nolvadex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcoholism (Phase 3)

Liver Diseases (Phase 3)

Liver Diseases, Alcoholic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 7